Study List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Report Bug
Study List
You are on Page 773 of 776:
763 764 765 766 767 768 769 770 771 772 773 774 775 776

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00002720 European Institute of Oncology COMPLETED Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer PHASE3 View
NCT00002718 Memorial Sloan Kettering Cancer Center COMPLETED T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia PHASE2 View
NCT00002708 Positive Gene Therapy Radiation Therapy Oncology Group COMPLETED Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases PHASE3 View
NCT00002705 National Cancer Institute (NCI) COMPLETED Topotecan in Treating Children With Refractory Leukemia PHASE1 View
NCT00002704 National Cancer Institute (NCI) COMPLETED Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia PHASE2 View
NCT00002703 Proton Radiation Oncology Group COMPLETED Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer PHASE3 View
NCT00002702 European Institute of Oncology UNKNOWN Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx PHASE3 View
NCT00002695 ECOG-ACRIN Cancer Research Group COMPLETED Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck View
NCT00002693 Mayo Clinic COMPLETED Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia PHASE1 View
NCT00002692 Positive Gene Therapy Medical Research Council UNKNOWN Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver PHASE3 View
NCT00002669 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE2 View
NCT00002668 Eastern Cooperative Oncology Group TERMINATED Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer NA View
NCT00002667 Eastern Cooperative Oncology Group COMPLETED Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer NA View
NCT00002659 Matrix Pharmaceutical UNKNOWN Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer PHASE3 View
NCT00002658 Medical Research Council UNKNOWN Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia PHASE3 View
NCT00002657 SWOG Cancer Research Network COMPLETED SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant PHASE2 View
NCT00002656 Positive Gene Therapy Barbara Ann Karmanos Cancer Institute COMPLETED Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer PHASE2 View
NCT00002651 SWOG Cancer Research Network COMPLETED SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer PHASE3 View
NCT00002650 Eastern Cooperative Oncology Group COMPLETED High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed PHASE2 View
NCT00002635 Yale University COMPLETED Aminocamptothecin in Treating Patients With T-cell Lymphoma PHASE2 View
NCT00002634 Memorial Sloan Kettering Cancer Center COMPLETED Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma PHASE2 View
NCT00002633 Positive Gene Therapy NCIC Clinical Trials Group COMPLETED Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer PHASE3 View
NCT00002632 Eastern Cooperative Oncology Group COMPLETED Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer PHASE2 View
NCT00002620 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Radiation Therapy in Treating Patients With Brain Cancer PHASE3 View
NCT00002618 Children's Oncology Group COMPLETED Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma PHASE3 View
NCT00002616 University of Illinois at Chicago UNKNOWN Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer PHASE1 View
NCT00002604 Case Comprehensive Cancer Center COMPLETED O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors PHASE1 View
NCT00002602 Radiation Therapy Oncology Group COMPLETED Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer PHASE1 View
NCT00002600 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins COMPLETED Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer PHASE1 View
NCT00002595 Advocate Lutheran General Hospital COMPLETED Toremifene in Treating Patients With Desmoid Tumors PHASE2 View
NCT00002594 Children's Oncology Group COMPLETED Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors PHASE2 View
NCT00002593 SWOG Cancer Research Network COMPLETED S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed PHASE3 View
NCT00002592 Abramson Cancer Center at Penn Medicine COMPLETED Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia PHASE2 View
NCT00002569 Radiation Therapy Oncology Group COMPLETED Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma PHASE3 View
NCT00002568 Gynecologic Oncology Group COMPLETED Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer PHASE3 View
NCT00002567 Memorial Sloan Kettering Cancer Center COMPLETED High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission PHASE2 View
NCT00002566 UNICANCER COMPLETED Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors PHASE3 View
NCT00002561 Positive Gene Therapy NCIC Clinical Trials Group COMPLETED Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease PHASE3 View
NCT00002560 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma PHASE2 View
NCT00002559 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin PHASE1 View
NCT00002558 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors PHASE1 View
NCT00002557 National Cancer Institute (NCI) UNKNOWN Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides PHASE2 View
NCT00002556 National Cancer Institute (NCI) COMPLETED Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma PHASE3 View
NCT00002551 SWOG Cancer Research Network COMPLETED SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed PHASE3 View
NCT00002550 Radiation Therapy Oncology Group COMPLETED Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer PHASE3 View
NCT00002535 St. Luke's Medical Center COMPLETED Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma PHASE2 View
NCT00002534 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission PHASE3 View
NCT00002533 University of Miami COMPLETED Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer PHASE2 View
NCT00002532 Hannover Medical School UNKNOWN Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia PHASE2 View
NCT00002520 Eastern Cooperative Oncology Group COMPLETED Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer NA View
NCT00002505 Hoag Memorial Hospital Presbyterian COMPLETED Tumor Cell Vaccine in Treating Patients With Advanced Cancer PHASE2 View
NCT00002504 Hoag Memorial Hospital Presbyterian COMPLETED Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer PHASE2 View
NCT00002503 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases PHASE3 View
NCT00002502 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome PHASE2 View
NCT00002495 Positive Gene Therapy SWOG Cancer Research Network COMPLETED SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease PHASE3 View
NCT00002494 Alliance for Clinical Trials in Oncology COMPLETED Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia PHASE2 View
NCT00002493 Gynecologic Oncology Group COMPLETED Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer PHASE3 View
NCT00002492 University of Miami COMPLETED Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma PHASE2 View
NCT00002466 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer PHASE2 View
NCT00002461 Montefiore Medical Center COMPLETED Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma PHASE2 View
NCT00002460 Cancer Research UK UNKNOWN Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer PHASE3 View
NCT00002459 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus PHASE3 View
NCT00002458 Memorial Sloan Kettering Cancer Center COMPLETED Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission PHASE2 View
NCT00002456 Fred Hutchinson Cancer Center COMPLETED Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation PHASE3 View
NCT00002451 Merck Sharp & Dohme LLC UNKNOWN Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs PHASE2 View
NCT00002450 Gilead Sciences COMPLETED Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients PHASE3 View
NCT00002435 Pharmacia COMPLETED A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients PHASE2 View
NCT00002434 Positive Gene Therapy U.S. Bioscience COMPLETED A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP) NA View
NCT00002433 Positive Gene Therapy Amgen COMPLETED The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS NA View
NCT00002432 Astra USA COMPLETED A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS NA View
NCT00002427 Research Institute for Genetic and Human Therapy COMPLETED Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults PHASE1 View
NCT00002420 Bristol-Myers Squibb TERMINATED The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors PHASE2 View
NCT00002418 Bristol-Myers Squibb TERMINATED The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors PHASE2 View
NCT00002406 Merck Sharp & Dohme LLC COMPLETED A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients PHASE3 View
NCT00002405 Positive Gene Therapy Glaxo Wellcome COMPLETED A Study of Amprenavir in HIV-Infected Patients NA View
NCT00002404 Glaxo Wellcome COMPLETED The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients NA View
NCT00002403 Aronex Pharmaceuticals COMPLETED Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients PHASE1 View
NCT00002402 VaxGen COMPLETED A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines PHASE1 View
NCT00002395 Positive Gene Therapy SmithKline Beecham COMPLETED Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML) PHASE2 View
NCT00002394 Novartis COMPLETED Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment NA View
NCT00002393 Dupont Merck COMPLETED A Study of Indinavir Taken With or Without DMP 266 PHASE3 View
NCT00002392 Rockefeller University COMPLETED A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART NA View
NCT00002369 Bristol-Myers Squibb COMPLETED A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs NA View
NCT00002368 Boehringer Ingelheim COMPLETED The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs PHASE3 View
NCT00002367 Positive Gene Therapy Hoffmann-La Roche COMPLETED A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs PHASE3 View
NCT00002366 Abbott COMPLETED The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma PHASE2 View
NCT00002361 Merck Sharp & Dohme LLC COMPLETED Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors PHASE2 View
NCT00002360 Bristol-Myers Squibb COMPLETED A Study Comparing Two Forms of Didanosine in HIV-infected Patients PHASE1 View
NCT00002359 Positive Gene Therapy The Immune Response Corporation COMPLETED A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega PHASE3 View
NCT00002358 Bristol-Myers Squibb COMPLETED A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV PHASE3 View
NCT00002357 Hoechst Marion Roussel COMPLETED The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms PHASE2 View
NCT00002356 Ionis Pharmaceuticals, Inc. COMPLETED The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes PHASE2 View
NCT00002351 Merck Sharp & Dohme LLC COMPLETED A Study of L-735,524 in HIV-Positive Children and Adolescents PHASE1 View
NCT00002350 Apollon COMPLETED A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients PHASE1 View
NCT00002335 Glaxo Wellcome COMPLETED The Safety and Effectiveness of 524W91 PHASE1 View
NCT00002334 Hoffmann-La Roche COMPLETED A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment PHASE3 View
NCT00002333 Positive Gene Therapy Hoffmann-La Roche COMPLETED A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine PHASE2 View
NCT00002332 Immunobiology Research Institute COMPLETED A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs PHASE2 View
NCT00002320 Glaxo Wellcome COMPLETED A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past PHASE3 View
NCT00002318 Sequus Pharmaceuticals UNKNOWN A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma PHASE3 View
NCT00002305 Pfizer COMPLETED A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis NA View
NCT00002304 Pfizer COMPLETED A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems NA View
NCT00002303 Ortho Pharmaceuticals COMPLETED The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic NA View
NCT00002302 Ortho Pharmaceuticals COMPLETED The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT NA View
NCT00002295 Newport Pharmaceuticals International COMPLETED A Study of Isoprinosine in Patients With Severe AIDS NA View
NCT00002294 Pfizer COMPLETED A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS NA View
NCT00002293 Bristol-Myers Squibb COMPLETED A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes NA View
NCT00002292 LyphoMed COMPLETED A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS NA View
NCT00002269 HEM Research COMPLETED A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen NA View
NCT00002268 Sandoz COMPLETED A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria PHASE1 View
NCT00002267 Pharmacia COMPLETED Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial NA View
NCT00002266 Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients NA View
NCT00002261 Bristol-Myers Squibb COMPLETED A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers PHASE1 View
NCT00002260 Lederle Laboratories COMPLETED An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects NA View
NCT00002259 Lederle Laboratories COMPLETED Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma PHASE2 View
NCT00002258 Sandoz COMPLETED A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia PHASE1 View
NCT00002257 Hoffmann-La Roche COMPLETED A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS NA View
NCT00002256 Hoffmann-La Roche COMPLETED Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy. NA View
NCT00002251 Hoffmann-La Roche COMPLETED A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir NA View
NCT00002250 Genentech, Inc. COMPLETED A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura PHASE1 View
NCT00002235 Merck Sharp & Dohme LLC COMPLETED A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors PHASE2 View
NCT00002234 Positive Gene Therapy Gilead Sciences COMPLETED Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients PHASE2 View
NCT00002233 Positive Gene Therapy Glaxo Wellcome COMPLETED A Study of a Combination of Four Drugs in Patients With Recent HIV Infection PHASE2 View
NCT00002232 Wyeth-Lederle Vaccines COMPLETED A Study of GENEVAX-HIV, a Possible Vaccine PHASE1 View
NCT00002227 Dupont Merck COMPLETED A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs PHASE2 View
NCT00002220 Merck Sharp & Dohme LLC COMPLETED Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir PHASE3 View
NCT00002218 Parke-Davis COMPLETED A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients PHASE1 View
NCT00002206 Gilead Sciences COMPLETED A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs PHASE1 View
NCT00002205 Glaxo Wellcome COMPLETED An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen NA View
NCT00002204 Chiron Corporation COMPLETED A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults PHASE1 View
NCT00002203 Positive Gene Therapy Glaxo Wellcome COMPLETED A Study of Two Anti-HIV Drug Combinations NA View
NCT00002202 Glaxo Wellcome COMPLETED A Comparison of 141W94 and Indinavir in HIV-Infected Patients PHASE3 View
NCT00002195 Glaxo Wellcome COMPLETED A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients PHASE3 View
NCT00002194 Boehringer Ingelheim COMPLETED An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. PHASE1 View
NCT00002193 Glaxo Wellcome COMPLETED Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors PHASE3 View
NCT00002192 Anderson Clinical Research COMPLETED Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. PHASE2 View
NCT00002169 Agouron Pharmaceuticals COMPLETED A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis PHASE2 View
NCT00002168 Bristol-Myers Squibb COMPLETED A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients NA View
NCT00002167 Clinical Solutions COMPLETED Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. PHASE2 View
NCT00002166 Boehringer Ingelheim COMPLETED An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease PHASE3 View
NCT00002161 Gilead Sciences COMPLETED A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 NA View
NCT00002160 Neurex COMPLETED A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain PHASE2 View
NCT00002159 Janssen, LP COMPLETED A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis PHASE3 View
NCT00002158 Romark Laboratories L.C. UNKNOWN A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis NA View
NCT00002157 Celgene Corporation COMPLETED Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome NA View
NCT00002156 Ionis Pharmaceuticals, Inc. COMPLETED A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) PHASE2 View
NCT00002151 Hoechst Marion Roussel COMPLETED A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients PHASE2 View
NCT00002150 Hoechst Marion Roussel COMPLETED A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients PHASE2 View
NCT00002135 Hoffmann-La Roche COMPLETED An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access NA View
NCT00002134 Roche Global Development COMPLETED A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis NA View
NCT00002133 Positive Gene Therapy Janssen, LP COMPLETED An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects. NA View
NCT00002132 Janssen Pharmaceuticals COMPLETED Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. NA View
NCT00002120 U.S. Bioscience COMPLETED Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia PHASE1 View
NCT00002118 Hoffmann-La Roche COMPLETED An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies NA View
NCT00002105 Sequus Pharmaceuticals COMPLETED Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma PHASE3 View
NCT00002104 Aaron Diamond AIDS Research Center COMPLETED Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV PHASE1 View
NCT00002103 U.S. Bioscience COMPLETED A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia NA View
NCT00002102 U.S. Bioscience COMPLETED A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia. NA View
NCT00002095 Hoffmann-La Roche COMPLETED A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus NA View
NCT00002094 Pharmacia and Upjohn COMPLETED Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E NA View
NCT00002093 Nexstar Pharmaceuticals COMPLETED A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. PHASE3 View
NCT00002092 Community Research Initiative of New England COMPLETED A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection NA View
NCT00002069 Merieux Institute COMPLETED A Study of DTC in Patients With AIDS and AIDS Related Complex NA View
NCT00002068 Positive Gene Therapy Pfizer COMPLETED A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis NA View
NCT00002067 Bristol-Myers Squibb COMPLETED A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia PHASE3 View
NCT00002066 Immunobiology Research Institute COMPLETED Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection NA View
NCT00002061 Newport Pharmaceuticals International COMPLETED A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy NA View
NCT00002060 Newport Pharmaceuticals International COMPLETED A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC) NA View
NCT00002059 Newport Pharmaceuticals International COMPLETED A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers NA View
NCT00002058 Positive Gene Therapy University of California, San Francisco COMPLETED A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease NA View
NCT00002057 Bristol-Myers Squibb COMPLETED Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC NA View
NCT00002056 Positive Gene Therapy LyphoMed COMPLETED A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS NA View
NCT00002051 Immunobiology Research Institute COMPLETED Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection NA View
NCT00002050 Immunobiology Research Institute COMPLETED A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients NA View
NCT00002035 Bristol-Myers Squibb COMPLETED Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine NA View
NCT00002034 Hoffmann-La Roche COMPLETED A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS NA View
NCT00002033 Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease NA View
NCT00002032 Positive Gene Therapy Pharmacia COMPLETED Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial NA View
NCT00002027 Janssen, LP COMPLETED Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) NA View
NCT00002020 Glaxo Wellcome COMPLETED Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC NA View
NCT00002018 Interferon Sciences COMPLETED Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects NA View
NCT00002006 Sandoz COMPLETED A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility PHASE1 View
NCT00002005 Genentech, Inc. COMPLETED A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex NA View
NCT00002004 Genentech, Inc. COMPLETED A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex PHASE1 View
NCT00002003 Lederle Laboratories COMPLETED Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas PHASE2 View
NCT00002002 Lederle Laboratories COMPLETED A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome NA View
NCT00001995 Pharmacia COMPLETED A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS NA View
NCT00001994 Glaxo Wellcome COMPLETED A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine NA View
NCT00001993 G D Searle COMPLETED Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3 PHASE2 View
NCT00001992 Genentech, Inc. COMPLETED A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers PHASE1 View
NCT00001969 National Institute of Mental Health (NIMH) COMPLETED Heart Disease Risk Factors in Major Depression View
NCT00001968 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Once-Daily Drug Regimen for HIV-Infected Patients PHASE1 View
NCT00001967 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Intermittent Versus Continuous Medication in the Treatment of HIV PHASE4 View
NCT00001966 National Human Genome Research Institute (NHGRI) COMPLETED Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome PHASE2 View
NCT00001961 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED MRI Evaluation of Chest Pain PHASE2 View
NCT00001960 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart Muscle PHASE2 View
NCT00001959 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) COMPLETED Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) PHASE2 View
NCT00001958 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) COMPLETED Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia) PHASE2 View
NCT00001957 National Institute on Deafness and Other Communication Disorders (NIDCD) COMPLETED Testing a Possible Cause of Reduced Ability of Children to Process Speech in Noise View
NCT00001956 National Institute of Dental and Craniofacial Research (NIDCR) COMPLETED Influence of Genetics in Pain Sensitivity PHASE2 View